Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C8 | P10632 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | RORC | P51449 | 1/20 | 0.31 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10143359 | 0.82 | FFAR4 (0.36) | RORC | |
| SCHEMBL12674114 | 0.75 | CYP2C8 (0.40) | CYP2C8KMT2A | |
| SCHEMBL14802267 | 0.75 | CYP2C8 (0.51) | CYP2C8KMT2AMEN1RORC | |
| SCHEMBL10078213 | 0.74 | CYP2C8 (0.51) | CYP2C8KMT2AMEN1RORCRIPK1 | |
| SCHEMBL12673666 | 0.73 | CYP2C8 (0.39) | CYP2C8KMT2A | |
| SCHEMBL13395084 | 0.73 | CYP2C8 (0.46) | CYP2C8KMT2AMEN1RORCRIPK1 | |
| SCHEMBL12665086 | 0.73 | CYP2C8 (0.55) | CYP2C8KMT2AMEN1 | |
| SCHEMBL12665358 | 0.73 | CYP2C8 (0.51) | CYP2C8KMT2AMEN1 | |
| SCHEMBL13395063 | 0.73 | CYP2C8 (0.44) | CYP2C8KMT2AMEN1RORC | |
| SCHEMBL13395078 | 0.73 | CYP2C8 (0.45) | CYP2C8KMT2AMEN1RORC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2195317-B1 | 2,3-SUBSTITUTED AZAINDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS | SCHERING CORP (US) | 2012-01-18 | — | — | EP | disclosed |
| WO-2009032125-A1 | 2,3-SUBSTITUTED AZAINDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS | SCHERING CORPORATION (US) | 2009-03-12 | — | — | WO | disclosed |